CD4⁺ T cell–independent DNA vaccination against opportunistic infections
J. Clin. Invest. Mingquan Zheng, et al. 115:3536 doi:10.1172/JCI26306 [Go to this article.]

Figure 2
Anti-OVA IgG1 (A) and IgG2a (B) responses after AdOVA or AdOVA/CD40L boosting after intramuscular DNA priming with pOVA or pOVA/CD40L in CD4-depleted and CD4-replete mice. n = 6–8 per group All data are mean titer ± SEM. *P < 0.05 compared with control; **P < 0.01 compared with control. A line denotes the limit of detection in the ELISA.